Mepolizumab effectiveness and identification of super-responders in severe asthma

Erin S. Harvey, David Langton, Constance H. Katelaris, +25

European Respiratory Journal

Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life

Tunn Ren Tay, Naghmeh Radhakrishna, Fiona Hore‐Lacy, +4

Respirology

Treatable traits can be identified in a severe asthma registry and predict future exacerbations

Vanessa M. McDonald, Sarah A. Hiles, Krystelle Godbout, +36

Respirology

Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

John W. Upham, Chantal Le Lievre, David J. Jackson, +114

The Journal of Allergy and Clinical Immunology In Practice

AsthmaAllergyAllergy MedicinePulmonary MedicineDelphi Process +4

Nonadherence in the era of severe asthma biologics and thermoplasty

Joy Lee, Tunn Ren Tay, Naghmeh Radhakrishna, +6

European Respiratory Journal

Working while unwell: Workplace impairment in people with severe asthma

Sarah A. Hiles, Erin S. Harvey, Vanessa M. McDonald, +35

Clinical & Experimental Allergy

Nontypeable Haemophilus influenzae Induces Sustained Lung Oxidative Stress and Protease Expression

Paul T. King, Roleen Sharma, Kim M. O’Sullivan, +19

PLoS ONE

InflammationProtease InhibitorsAsthmaInflammatory Lung DiseaseLung Inflammation +12

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

Dennis Thomas, Vanessa M. McDonald, Sean Stevens, +26

Allergy

Factors Associated with Dysfunctional Breathing in Patients with Difficult to Treat Asthma

Eve Denton, Janet Bondarenko, TunnRen Tay, +8

The Journal of Allergy and Clinical Immunology In Practice

A Structured Approach to Specialist-referred Difficult Asthma Patients Improves Control of Comorbidities and Enhances Asthma Outcomes

Tunn Ren Tay, Joy Lee, Naghmeh Radhakrishna, +6

The Journal of Allergy and Clinical Immunology In Practice

AsthmaPulmonary CareStructured ApproachAllergyEnhances Asthma Outcomes +3